These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15220415)

  • 1. Exchanging the yellow fever virus envelope proteins with Modoc virus prM and E proteins results in a chimeric virus that is neuroinvasive in SCID mice.
    Charlier N; Molenkamp R; Leyssen P; Paeshuyse J; Drosten C; Panning M; De Clercq E; Bredenbeek PJ; Neyts J
    J Virol; 2004 Jul; 78(14):7418-26. PubMed ID: 15220415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice.
    Nickells M; Chambers TJ
    J Virol; 2003 Nov; 77(22):12232-42. PubMed ID: 14581560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses.
    Caufour PS; Motta MC; Yamamura AM; Vazquez S; Ferreira II; Jabor AV; Bonaldo MC; Freire MS; Galler R
    Virus Res; 2001 Nov; 79(1-2):1-14. PubMed ID: 11551641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response.
    van Der Most RG; Murali-Krishna K; Ahmed R; Strauss JH
    J Virol; 2000 Sep; 74(17):8094-101. PubMed ID: 10933719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid and convenient variant of fusion-PCR to construct chimeric flaviviruses.
    Charlier N; Molenkamp R; Leyssen P; Vandamme AM; De Clercq E; Bredenbeek P; Neyts J
    J Virol Methods; 2003 Mar; 108(1):67-74. PubMed ID: 12565155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
    Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties.
    Chambers TJ; Nestorowicz A; Mason PW; Rice CM
    J Virol; 1999 Apr; 73(4):3095-101. PubMed ID: 10074160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of attenuation in the envelope protein of the flavivirus Alfuy.
    Prow NA; May FJ; Westlake DJ; Hurrelbrink RJ; Biron RM; Leung JY; McMinn PC; Clark DC; Mackenzie JS; Lobigs M; Khromykh AA; Hall RA
    J Gen Virol; 2011 Oct; 92(Pt 10):2286-2296. PubMed ID: 21733886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of the premembrane and envelope protein genes of Modoc virus with the homologous sequences of West Nile virus generates a chimeric virus that replicates in vertebrate but not mosquito cells.
    Saiyasombat R; Carrillo-Tripp J; Miller WA; Bredenbeek PJ; Blitvich BJ
    Virol J; 2014 Aug; 11():150. PubMed ID: 25151534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.
    Monath TP; Arroyo J; Levenbook I; Zhang ZX; Catalan J; Draper K; Guirakhoo F
    J Virol; 2002 Feb; 76(4):1932-43. PubMed ID: 11799188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.
    Chambers TJ; Liang Y; Droll DA; Schlesinger JJ; Davidson AD; Wright PJ; Jiang X
    J Virol; 2003 Mar; 77(6):3655-68. PubMed ID: 12610141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
    Monath TP; Levenbook I; Soike K; Zhang ZX; Ratterree M; Draper K; Barrett AD; Nichols R; Weltzin R; Arroyo J; Guirakhoo F
    J Virol; 2000 Feb; 74(4):1742-51. PubMed ID: 10644345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes.
    Bonaldo MC; Mello SM; Trindade GF; Rangel AA; Duarte AS; Oliveira PJ; Freire MS; Kubelka CF; Galler R
    Virol J; 2007 Oct; 4():115. PubMed ID: 17971212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone.
    Chambers TJ; Nickells M
    J Virol; 2001 Nov; 75(22):10912-22. PubMed ID: 11602731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage In vitro is lethal for virus production.
    Lee E; Stocks CE; Amberg SM; Rice CM; Lobigs M
    J Virol; 2000 Jan; 74(1):24-32. PubMed ID: 10590087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication of not-known-vector flaviviruses in mosquito cells is restricted by intracellular host factors rather than by the viral envelope proteins.
    Charlier N; Davidson A; Dallmeier K; Molenkamp R; De Clercq E; Neyts J
    J Gen Virol; 2010 Jul; 91(Pt 7):1693-7. PubMed ID: 20219898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.